FDA Supports Emerging Tech with Case Studies (24/33) 📊

CDER Office of Pharmaceutical Quality’s Thomas O’Connor shares why research is needed to support CDER’s Emerging Technology Program. He describes how OPQ’s research has impacted CDER’s assessment of
Emerging Technologies and discusses opportunities to collaborate with the CDER to advance the scientific understanding of how emerging technologies impact pharmaceutical quality.

Learn more at: https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/regulatory-education-industry-redi-pharmaceutical-quality-symposium-oct-16-17-2019


_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Visit https://www.fda.gov/cdersbia and https://www.fda.gov/cdersbialearn for news and a repository of training activities.

Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
LinkedIn: https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance
Twitter: https://twitter.com/FDA_Drug_Info
CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionmanagement